Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A general method for exploiting QSAR models in lead optimization.

Richard A Lewis1

  • 1Computer-Aided Drug Design, Eli Lilly and Company Limited, Windlesham, Surrey GU20 6PH, United Kingdom. Richard.lewis@pharma.novartis.com

Journal of Medicinal Chemistry
|March 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Austin Sumner 1938-2025.

Neurology·2026
Same author

Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].

Journal of the neurological sciences·2026
Same author

Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20.

Journal of the neurological sciences·2026
Same author

Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial.

Therapeutic advances in neurological disorders·2026
Same author

Expanding the Clinical and Molecular Spectrum of <i>TUBB2B</i> Through Distinct Variants Identified Across Multiple Families.

medRxiv : the preprint server for health sciences·2026
Same author

CEP76 impairment at the centrosome-cilium interface contributes to a spectrum of ciliopathies.

Science advances·2025
Same journal

Small Molecules in Development for the Treatment of Sepsis: Insights into Drug Targets and Molecular Mechanisms.

Journal of medicinal chemistry·2026
Same journal

Isofagomine Derivatives as TcdB Glucosyltransferase Inhibitors.

Journal of medicinal chemistry·2026
Same journal

The One-Step Incorporation of Boron-10 Atom into Prostate Cancer-Targeted Fluorophores for Visualizing In Vivo Boron-10 Delivery and Intratumoral Distribution with Cellular Resolution.

Journal of medicinal chemistry·2026
Same journal

Design and Evaluation of Conformationally Locked Indole-Carboxylic Acids as Selective THRβ Agonists against MASH.

Journal of medicinal chemistry·2026
Same journal

Drug Screening of Nitroreductase Modulators Using an Atomic-Engineered Activatable Fluorescent Probe for Tumor Imaging.

Journal of medicinal chemistry·2026
Same journal

Reprogramming Acetaminophen Metabolism via Amide-to-Thioamide Modification to Prevent Drug-Induced Liver Injury.

Journal of medicinal chemistry·2026
See all related articles

This study introduces an automated protocol for quantitative structure-activity relationship (QSAR) studies. The new method enhances model interpretability, aiding medicinal chemists in designing more active drug compounds.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Design

Background:

  • Computer-aided drug design (CADD) employs quantitative structure-activity relationship (QSAR) models for predicting molecular activity.
  • Current QSAR models often lack interpretability, making it difficult for chemists to guide structural modifications for improved drug potency.
  • Enhancing model interpretability is crucial for optimizing the drug design process.

Purpose of the Study:

  • To develop and present a novel protocol for automated, iterative quantitative structure-activity relationship (QSAR) studies.
  • To improve the interpretability of QSAR models for medicinal chemists.
  • To assist chemists in identifying promising structural modifications for next-generation drug candidates.

Main Methods:

Related Experiment Videos

  • Development of an automated iterative protocol for QSAR analysis.
  • Application of the protocol to two established QSAR datasets from scientific literature.
  • Evaluation of model performance and interpretability.

    • Main Results:

    • The developed protocol facilitates automated and iterative QSAR studies.
    • Experiments demonstrate the protocol's applicability and effectiveness on literature datasets.
    • The approach aims to provide clearer insights into structure-activity relationships.

    Conclusions:

    • The new protocol enhances the utility of QSAR in drug design by improving model interpretability.
    • This work provides a valuable tool to aid medicinal chemists in the rational design of more active compounds.
    • Further application of this method can accelerate the drug discovery pipeline.